Avastin (bevacizumab), a VEGF-blocking chemotherapy drug, is prescribed because cancers overexpress VEGF and are heavily vascularized; thus, peptides like BPC-157 that increase VEGF and blood flow are contraindicated in anyone with active malignancy because they would feed tumor growth.
causalpending
Speaker
Dr. Kyle GilletteEvidence Quote
“cancers tend to overexpress vegf and they tend to be well vascularized so you don't want to send even more blood flow to something that's so hungry for blood flow that it's growing”
Source
Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauerCreated: 8/13/2026, 4:51:25 AM
My Notes
Loading notes...